My WebLink
|
Help
|
About
|
Sign Out
Home
Search
04-24-2023 City Council Packet
LinoLakes
>
City Council
>
City Council Meeting Packets
>
2023
>
Searchable Packets
>
04-24-2023 City Council Packet
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/26/2023 12:57:52 PM
Creation date
4/26/2023 12:56:27 PM
Metadata
Fields
Template:
City Council
Council Document Type
Council Packet
Meeting Date
04/24/2023
Council Meeting Type
Regular
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
115
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
PART TWO: PREVENTION <br />8 <br />being removed from the home and/or placed in foster care due to custodial opioid <br />use. <br />F.PREVENT OVER-PRESCRIBING AND ENSURE APPROPRIATE <br />PRESCRIBING AND DISPENSING OF OPIOIDS <br />Support efforts to prevent over-prescribing and ensure appropriate prescribing and <br />dispensing of opioids through evidence-based or evidence-informed programs or <br />strategies that may include, but are not limited to, the following: <br />1.Funding medical provider education and outreach regarding best prescribing <br />practices for opioids consistent with the Guidelines for Prescribing Opioids for <br />Chronic Pain from the U.S. Centers for Disease Control and Prevention, including <br />providers at hospitals (academic detailing). <br />2.Training for health care providers regarding safe and responsible opioid <br />prescribing, dosing, and tapering patients off opioids. <br />3.Continuing Medical Education (CME) on appropriate prescribing of opioids. <br />4.Providing Support for non-opioid pain treatment alternatives, including training <br />providers to offer or refer to multi-modal, evidence-informed treatment of pain. <br />5.Supporting enhancements or improvements to Prescription Drug Monitoring <br />Programs (“PDMPs”), including, but not limited to, improvements that: <br />1.Increase the number of prescribers using PDMPs; <br />2.Improve point-of-care decision-making by increasing the quantity, quality, <br />or format of data available to prescribers using PDMPs, by improving the <br />interface that prescribers use to access PDMP data, or both; or <br />3.Enable states to use PDMP data in support of surveillance or intervention <br />strategies, including MOUD referrals and follow-up for individuals <br />identified within PDMP data as likely to experience OUD in a manner that <br />complies with all relevant privacy and security laws and rules. <br />6.Ensuring PDMPs incorporate available overdose/naloxone deployment data, <br />including the United States Department of Transportation’s Emergency Medical <br />Technician overdose database in a manner that complies with all relevant privacy <br />and security laws and rules. <br />7.Increasing electronic prescribing to prevent diversion or forgery. <br />8.Educating dispensers on appropriate opioid dispensing. <br />DocuSign Envelope ID: 040056EC-0D41-4D98-9C65-E01AE876A6AB
The URL can be used to link to this page
Your browser does not support the video tag.